STOCK TITAN

Freightos (CRGO) CSO tax-related sale of 3,901 shares, retains options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Freightos Ltd Chief Strategy Officer Ian Arroyo reported a small tax-related share sale. On July 2, 2026, he sold 3,901 ordinary shares at $1.31 per share to cover withholding tax from vesting RSUs, leaving 32,099 ordinary shares held directly. He also retains stock options over 228,674, 12,314 and 49,473 ordinary shares at exercise prices of $4.17 and $1.07.

Positive

  • None.

Negative

  • None.
Insider Arroyo Ian
Role Chief Strategy Officer
Sold 3,901 shs ($5K)
Type Security Shares Price Value
Sale Ordinary Shares 3,901 $1.31 $5K
holding Stock Option (right to buy) -- -- --
holding Stock Option (right to buy) -- -- --
holding Stock Option (right to buy) -- -- --
holding Ordinary Shares -- -- --
holding Ordinary Shares -- -- --
holding Ordinary Shares -- -- --
holding Ordinary Shares -- -- --
holding Ordinary Shares -- -- --
holding Ordinary Shares -- -- --
holding Ordinary Shares -- -- --
holding Ordinary Shares -- -- --
Holdings After Transaction: Ordinary Shares — 32,099 shares (Direct, null); Stock Option (right to buy) — 49,473 shares (Direct, null)
Footnotes (1)
  1. The transaction reported in this row consists of the sale of ordinary shares on behalf of the Reporting Person to satisfy applicable withholding tax obligations arising from the vesting of restricted share units ("RSUs") previously granted by the Issuer to the Reporting Person. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 36,000 RSUs originally granted to the Reporting Person by the Issuer that began vesting on July 1, 2025. 33.33% of such RSUs vested on July 1, 2026 (the one-year anniversary of the vesting commencement date), and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter), such that all such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be fully vested by the three-year anniversary of the vesting commencement date (July 1, 2028). There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025. The 7,000 RSUs originally granted vest (and settle for underlying ordinary shares) on an equal, quarterly basis over three calendar quarters (33.33% per quarter) such that all such 7,000 RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be vested by July 15, 2026. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025. The 21,500 RSUs originally granted vest (and settle for underlying ordinary shares) on an equal, quarterly basis over seven calendar quarters (approximately 14.286% per quarter) such that all such 21,500 RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be vested by July 15, 2027. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 31, 2027. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on July 15, 2026. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2026. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2027. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person that were granted to, and began vesting for, the Reporting Person on April 1, 2026 and that vest and settle for underlying ordinary shares based on the following schedule: 33% of the subject RSUs will vest upon the one-year anniversary of the grant date (April 1, 2027), and the remainder of the RSUs will vest in eight equal installments at the conclusion of each of the following eight quarters (8.25% per quarter), such that the RSUs will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2029).
Shares sold 3,901 shares Ordinary shares sold on July 2, 2026
Sale price $1.31 per share Price for 3,901 ordinary shares sold
Shares held after sale 32,099 shares Direct ordinary share holdings following transaction
Option grant 1 228,674 underlying shares at $4.17 Stock option, expiration February 17, 2032
Option grant 2 12,314 underlying shares at $4.17 Stock option, expiration July 19, 2031
Option grant 3 49,473 underlying shares at $1.07 Stock option, expiration December 16, 2030
Net share activity -3,901 shares Net buy/sell shares in this filing (net-sell)
withholding tax obligations financial
"sale of ordinary shares on behalf of the Reporting Person to satisfy applicable withholding tax obligations"
restricted share units ("RSUs") financial
"arising from the vesting of restricted share units ("RSUs") previously granted"
Stock Option (right to buy) financial
"security_title": "Stock Option (right to buy)""
vesting financial
"RSUs originally granted vest (and settle for underlying ordinary shares) on an equal, quarterly basis"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
underlying ordinary shares financial
"vest (and settle for underlying ordinary shares) in their entirety"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did Freightos (CRGO) executive Ian Arroyo report in this Form 4?

Ian Arroyo reported a small sale of 3,901 Freightos ordinary shares. The sale was made to cover withholding tax from vesting restricted share units, and he continues to hold 32,099 shares plus several stock option awards over additional shares.

How many Freightos (CRGO) shares did Ian Arroyo sell and at what price?

Ian Arroyo sold 3,901 Freightos ordinary shares at $1.31 per share. According to the filing, this was an open-market or private sale specifically linked to satisfying tax obligations from RSU vesting, rather than a discretionary reduction of his equity position.

Why were Ian Arroyo’s Freightos (CRGO) shares sold according to the Form 4?

The filing states the 3,901 Freightos shares were sold to satisfy applicable withholding tax obligations on vesting RSUs. This means the transaction was driven by tax requirements on equity compensation, not by an independent investment decision to exit or reduce exposure.

How many Freightos (CRGO) shares does Ian Arroyo hold after this transaction?

After the tax-related sale, Ian Arroyo holds 32,099 Freightos ordinary shares directly. The Form 4 also shows multiple RSU-based positions and stock options that may deliver additional shares over time, separate from this relatively small share sale.

What stock options over Freightos (CRGO) shares does Ian Arroyo retain?

Ian Arroyo retains stock options over 228,674 and 12,314 underlying ordinary shares at an exercise price of $4.17, and 49,473 underlying shares at $1.07. These options give him the right to buy Freightos shares before their respective expiration dates.

Do the other ordinary share entries for Freightos (CRGO) reflect additional transactions?

The footnotes clarify that most other ordinary share rows reflect RSU-based holdings, not new trades. They describe vesting schedules for various RSU grants that settle into Freightos ordinary shares over time, with no transactions effected in some rows.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Arroyo Ian

(Last)(First)(Middle)
C/O FREIGHTOS LIMITED, PLANTA 10, AVDA.
DIAGONAL, 211

(Street)
BARCELONA08018

(City)(State)(Zip)

SPAIN

(Country)
2. Issuer Name and Ticker or Trading Symbol
Freightos Ltd [ CRGO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Strategy Officer
2a. Foreign Trading Symbol
[N/A]
3. Date of Earliest Transaction (Month/Day/Year)
07/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares07/02/2026S(1)3,901D$1.3132,099(2)D
Ordinary Shares(3)6,244(4)D
Ordinary Shares(3)20,505(5)D
Ordinary Shares(3)37,500(6)D
Ordinary Shares(3)37,500(7)D
Ordinary Shares(3)23,924D
Ordinary Shares(3)38,000(8)D
Ordinary Shares(3)38,000(9)D
Ordinary Shares(3)54,600(10)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)(3)$1.0712/01/202412/16/2030Ordinary Shares49,47349,473D
Stock Option (right to buy)(3)$4.1707/01/202507/19/2031Ordinary Shares12,31412,314D
Stock Option (right to buy)(3)$4.1701/01/202602/17/2032Ordinary Shares228,674228,674D
Explanation of Responses:
1. The transaction reported in this row consists of the sale of ordinary shares on behalf of the Reporting Person to satisfy applicable withholding tax obligations arising from the vesting of restricted share units ("RSUs") previously granted by the Issuer to the Reporting Person.
2. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 36,000 RSUs originally granted to the Reporting Person by the Issuer that began vesting on July 1, 2025. 33.33% of such RSUs vested on July 1, 2026 (the one-year anniversary of the vesting commencement date), and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter), such that all such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be fully vested by the three-year anniversary of the vesting commencement date (July 1, 2028).
3. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
4. The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025. The 7,000 RSUs originally granted vest (and settle for underlying ordinary shares) on an equal, quarterly basis over three calendar quarters (33.33% per quarter) such that all such 7,000 RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be vested by July 15, 2026.
5. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025. The 21,500 RSUs originally granted vest (and settle for underlying ordinary shares) on an equal, quarterly basis over seven calendar quarters (approximately 14.286% per quarter) such that all such 21,500 RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be vested by July 15, 2027.
6. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 31, 2027.
7. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on July 15, 2026.
8. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2026.
9. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2027.
10. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person that were granted to, and began vesting for, the Reporting Person on April 1, 2026 and that vest and settle for underlying ordinary shares based on the following schedule: 33% of the subject RSUs will vest upon the one-year anniversary of the grant date (April 1, 2027), and the remainder of the RSUs will vest in eight equal installments at the conclusion of each of the following eight quarters (8.25% per quarter), such that the RSUs will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2029).
Remarks:
Exhibit 24.1 - Power of Attorney.
/s/ Max Sitnick, Attorney-in-fact07/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)